{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:14:06Z","timestamp":1774368846349,"version":"3.50.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/gme.0b013e31827f06dc","type":"journal-article","created":{"date-parts":[[2013,3,12]],"date-time":"2013-03-12T12:30:54Z","timestamp":1363091454000},"page":"845-851","source":"Crossref","is-referenced-by-count":53,"title":["Hyperresistinemia is associated with postmenopausal breast cancer"],"prefix":"10.1097","volume":"20","author":[{"given":"Maria","family":"Dalamaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Karmaniolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Papadavid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaos","family":"Pelekanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Sotiropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antigoni","family":"Lekka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210211","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/gme.0b013e3181788d88","article-title":"Epidemiology, genetics, and risk evaluation of postmenopausal women at risk of breast cancer.","volume":"15","author":"Vogel","year":"2008","journal-title":"Menopause"},{"key":"R2-10-20210211","first-page":"1101","article-title":"Breast cancer and obesity, a dangerous relation.","volume":"8","author":"Zaman","year":"2012","journal-title":"Rev Med Suisse"},{"key":"R3-10-20210211","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/13697137.2012.666456","article-title":"Hormone therapy and breast cancer risk 10 years after the WHI.","volume":"15","author":"Gompel","year":"2012","journal-title":"Climacteric"},{"key":"R4-10-20210211","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-156-9-201205010-00006","article-title":"Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.","volume":"156","author":"Nelson","year":"2012","journal-title":"Ann Intern Med"},{"key":"R5-10-20210211","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1002\/ijc.21730","article-title":"Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort.","volume":"118","author":"Rinaldi","year":"2006","journal-title":"Int J Cancer"},{"key":"R6-10-20210211","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ijc.23303","article-title":"Early life events and conditions and breast cancer risk: from epidemiology to etiology.","volume":"122","author":"Trichopoulos","year":"2008","journal-title":"Int J Cancer"},{"key":"R7-10-20210211","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1470-2045(00)00254-0","article-title":"Epidemiology of breast cancer.","volume":"2","author":"Key","year":"2001","journal-title":"Lancet Oncol"},{"key":"R8-10-20210211","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1001\/jama.286.17.2143","article-title":"Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms.","volume":"286","author":"Singletary","year":"2001","journal-title":"JAMA"},{"key":"R9-10-20210211","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1467-789X.2004.00142.x","article-title":"Obesity, adipocytokines, and insulin resistance in breast cancer.","volume":"5","author":"Rose","year":"2004","journal-title":"Obesity Rev"},{"key":"R10-10-20210211","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.mehy.2012.07.036","article-title":"Nicotinamide phosphoribosyl-transferasevisfatin: a missing link between overweightobesity and postmenopausal breast cancer Potential preventive and therapeutic perspectives and challenges.","volume":"79","author":"Dalamaga","year":"2012","journal-title":"Med Hypotheses"},{"key":"R11-10-20210211","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1634\/theoncologist.2011-0050","article-title":"Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle.","volume":"16","author":"La Vecchia","year":"2011","journal-title":"Oncologist"},{"key":"R12-10-20210211","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1677\/erc.0.0060165","article-title":"Aromatase and breast cancer susceptibility.","volume":"6","author":"Pobst-Hensch","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"R14-10-20210211","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: the role of leptin in human physiology: emerging clinical applications.","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann Intern Med"},{"key":"R15-10-20210211","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1210\/er.2011-1015","article-title":"The role of adiponectin in cancer: a review of current evidence.","volume":"33","author":"Dalamaga","year":"2012","journal-title":"Endocr Rev"},{"key":"R16-10-20210211","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1210\/jc.2003-031804","article-title":"Adiponectin and breast cancer risk.","volume":"89","author":"Mantzoros","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-10-20210211","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clim.2009.07.013","article-title":"The role of resistin as a regulator of inflammation: implications for various human pathologies.","volume":"133","author":"Filkova","year":"2009","journal-title":"Clin Immunol"},{"key":"R18-10-20210211","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00535-009-0063-5","article-title":"Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer.","volume":"44","author":"Nakajima","year":"2009","journal-title":"J Gastroenterol"},{"key":"R19-10-20210211","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1349-7006.2010.01518.x","article-title":"Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.","volume":"101","author":"Nakajima","year":"2010","journal-title":"Cancer Sci"},{"key":"R20-10-20210211","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00384-008-0605-y","article-title":"Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients.","volume":"24","author":"Kumor","year":"2009","journal-title":"Int J Colorectal Dis"},{"key":"R21-10-20210211","first-page":"416","article-title":"Serum levels of adipokines resistin and leptin in patients with colon cancer.","volume":"3","author":"Salageanu","year":"2010","journal-title":"J Med Life"},{"key":"R22-10-20210211","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00384-009-0828-6","article-title":"Association between adiponectin, resistin, insulin resistance, and colorectal tumors.","volume":"25","author":"Gonullu","year":"2010","journal-title":"Int J Colorectal Dis"},{"key":"R23-10-20210211","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.cca.2012.01.019","article-title":"The role of resistin in colorectal cancer.","volume":"413","author":"Danese","year":"2012","journal-title":"Clin Chim Acta"},{"key":"R24-10-20210211","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3346\/jkms.2007.22.1.117","article-title":"Relationship of serum adiponectin and resistin levels with breast cancer risk.","volume":"22","author":"Kang","year":"2007","journal-title":"J Korean Med Sci"},{"key":"R25-10-20210211","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/00029330-200709020-00009","article-title":"Adipocytokines and breast cancer risk.","volume":"120","author":"Hou","year":"2007","journal-title":"Chin Med J"},{"key":"R27-10-20210211","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4149\/neo_2011_02_124","article-title":"Relationship of resistin levels with endometrial cancer risk.","volume":"58","author":"Hlavna","year":"2011","journal-title":"Neoplasma"},{"key":"R28-10-20210211","first-page":"442","article-title":"Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: possible role in cancer progression.","volume":"55","author":"Housa","year":"2008","journal-title":"Neoplasma"},{"key":"R29-10-20210211","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10552-008-9233-7","article-title":"Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study.","volume":"20","author":"Dalamaga","year":"2009","journal-title":"Cancer Causes Control"},{"key":"R30-10-20210211","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ejca.2008.04.015","article-title":"Adiponectin and resistin are associated with risk for myelodysplastic syndrome, independently from the insulin-like growth factor-I (IGF-I) system.","volume":"44","author":"Dalamaga","year":"2008","journal-title":"Eur J Cancer"},{"key":"R31-10-20210211","first-page":"241","article-title":"Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics.","volume":"28","author":"Pamuk","year":"2006","journal-title":"Exp Oncol"},{"key":"R32-10-20210211","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10549-010-0792-4","article-title":"Adipocytokine resistin and breast cancer risk.","volume":"123","author":"Sun","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"R33-10-20210211","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ygyno.2012.02.032","article-title":"Resistin expression in breast cancer tissue as a marker of prognosis and hormone therapy stratification.","volume":"125","author":"Lee","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R34-10-20210211","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1080\/10428190600688552","article-title":"Clinical study on the serum carcinoembryonic antigen, CA 19-9, CA 50, and -fetoprotein levels in patients with myelodysplastic syndromes.","volume":"47","author":"Dalamaga","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"R35-10-20210211","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000120995","article-title":"Circulating adiponectin and leptin in relation to myelodysplastic syndrome: a case-control study.","volume":"73","author":"Dalamaga","year":"2007","journal-title":"Oncology"},{"key":"R37-10-20210211","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/gme.0b013e31821e21f5","article-title":"Elevated serum visfatinnicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.","volume":"18","author":"Dalamaga","year":"2011","journal-title":"Menopause"},{"key":"R38-10-20210211","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.maturitas.2010.05.004","article-title":"Adipocyte factors, high-sensitive C-reactive protein levels and lipoxidative stress products in overweight postmenopausal women with normal and impaired OGTT.","volume":"67","author":"Kassi","year":"2010","journal-title":"Maturitas"},{"key":"R39-10-20210211","first-page":"1285","article-title":"Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin.","volume":"21","author":"Rose","year":"2002","journal-title":"Int J Oncol"},{"key":"R40-10-20210211","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jpeds.2012.05.063","article-title":"Serum resistin and inflammatory and endothelial activation markers in obese adolescents.","volume":"161","author":"Maggio","year":"2012","journal-title":"J Pediatr"},{"key":"R41-10-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/oby.2002.1","article-title":"Resistin gene expression in human adipocytes is not related to insulin resistance.","volume":"10","author":"Janke","year":"2002","journal-title":"Obes Res"},{"key":"R42-10-20210211","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1371\/journal.pone.0000031","article-title":"Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes.","volume":"1","author":"Nagaev","year":"2006","journal-title":"PLoS One"},{"key":"R43-10-20210211","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1677\/joe.1.06610","article-title":"Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes.","volume":"189","author":"Di Simone","year":"2006","journal-title":"J Endocrinol"},{"key":"R44-10-20210211","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.numecd.2009.04.015","article-title":"Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss.","volume":"20","author":"Balducci","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R45-10-20210211","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10549-009-0647-z","article-title":"Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy.","volume":"123","author":"Phoenix","year":"2010","journal-title":"Breast Cancer Res Treat"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GME.0b013e31827f06dc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:41:21Z","timestamp":1620952881000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201308000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31827f06dc","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}